Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Darmiyan
AddedMar 17, 2024
UpdatedJul 3, 2026
Darmiyan

Darmiyan

Series A

AI-driven MRI analysis for early Alzheimer's detection and diagnostic software services.

HQ
San Francisco, CA, US
Founded
2016
Accelerator
Y Combinator logoY CombinatorS17
Overview
Compare
Fundraising
Employees
Website

Darmiyan, founded with the mission to revolutionize the early detection of Alzheimer's disease, leverages advanced AI-driven MRI analysis to provide diagnostic software services. Their flagship product, BrainSee, offers novel quantitative virtual microscopy to detect Alzheimer's from non-invasive MRI scans, aiming to transform the landscape of neurodegenerative disease diagnostics.

Notable affiliations include a $6M investment led by pharmaceutical giant Eisai and recognition from Fortune for their CEO. BrainSee has been validated by third-party investigators and received FDA breakthrough designation, underscoring its potential impact. Darmiyan's innovative approach is poised to significantly advance early Alzheimer's detection, potentially improving patient outcomes and reducing healthcare costs.

Darmiyan - Similar Companies

Diamir logo

Diamir

diamirbio.com

ADM Diagnostics logo

ADM Diagnostics

admdx.com

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

Micsi logo

Micsi

micsi.co

Mrimath logo

Mrimath

Caire Health logo

Caire Health

cairehealth.com

Avalon AI logo

Avalon AI

avalonai.com

Piramidal logo

Piramidal

piramidal.ai

Durin Technologies logo

Durin Technologies

Scanbase logo

Scanbase

scanbase.com

RAD AI logo

RAD AI

radai.com

Altris.AI logo

Altris.AI

altris.ai

Vistim Labs logo

Vistim Labs

vistimlabs.com

Dasion logo

Dasion

dasion.ai

BrainKey logo

BrainKey

brainkey.ai

Darmiyan - Quick Facts

Who are Darmiyan's competitors?

Companies similar to Darmiyan include Diamir, ADM Diagnostics, NeuroVision Imaging and Micsi.

When was Darmiyan founded?

Darmiyan was founded in 2016.

Where is Darmiyan's headquarters located?

Darmiyan's headquarters is located in San Francisco, CA, US.

When was Darmiyan's last funding round?

Darmiyan's most recent funding round was for $3.5M (USD) in October 2023.

How much has Darmiyan raised to-date?

As of Oct 17, 2023, Darmiyan has raised a total of $14.5M (USD).

How many employees does Darmiyan have?

Darmiyan has 16 employees as of Feb 5, 2024.

Darmiyan - Classification

Industry
  • Professional Service Companies
Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Software
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 10 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified